Online first
Clinical vignette
Published online: 2024-11-13
Transcarotid aortic valve implantation using the novel Myval Octacor valve: First experience in Poland
Pubmed: 39535941
Abstract
Not available
References
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561–632.
- Terkelsen CJ, Thim T, Freeman P, et al. Randomized comparison of TAVI valves: The Compare-TAVI trial. Am Heart J. 2024; 274: 84–94.
- Kawashima H, Soliman O, Wang R, et al. Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trial. Am Heart J. 2021; 232: 23–38.
- Hegeman RR, van Ginkel DJ, Laengle S, et al. Preoperative computed tomography-imaging with patient-specific computer simulation in transcatheter aortic valve implantation: Design and rationale of the GUIDE-TAVI trial. Am Heart J. 2024; 269: 158–166.
- Trębacz J, Sobczyński R, Konstanty-Kalandyk J, et al. Transcarotid access for transcatheter aortic valve implantation with a Navitor device. Kardiol Pol. 2023; 81(2): 205–206.
